InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: Justfactsmam post# 293095

Monday, 04/20/2020 6:11:18 PM

Monday, April 20, 2020 6:11:18 PM

Post# of 403767
No doubt about more good exposure to Brilacidin from appearance on the updated JPMorgan list. https://www.jpmorgan.com/jpmpdf/1320748398702.pdf




From todays company pr: http://www.ipharminc.com/press-release/2020/4/20/screening-of-11552-compounds-identifies-innovation-pharmaceuticals-brilacidin-as-one-of-the-most-promising-potential-inhibitors-of-the-novel-coronavirus

Brilacidin is one of the few drugs targeting COVID-19 that has been tested in human trials for other clinical indications, providing an established safety and efficacy profile, thereby potentially enabling it to rapidly help address the emerging worldwide coronavirus crisis. Lab testing conducted at a U.S.-based Regional Biocontainment Laboratory (RBL) supports Brilacidin’s antiviral activity in directly inhibiting SARS-CoV-2 in cell-based assays. Additional pre-clinical and clinical data support Brilacidin’s therapeutic potential to inhibit the production of IL-6, IL-1b, TNF-a and other pro-inflammatory cytokines and chemokines (e.g., MCP-1), identified as central drivers in the worsening prognoses of COVID-19 patients. Brilacidin’s antimicrobial properties might also help in fighting secondary bacterial infections, which can co-present in up to 20 percent of COVID-19 patients. Collectively, these data support Brilacidin as a promising and unique (a 3 in 1 combination: antiviral, immune/anti-inflammatory, and antimicrobial) anti-COVID-19 therapeutic candidate.

For researchers and institutions interested in collaborating on Brilacidin for COVID-19, please send inquiries to: covid19@ipharminc.com










Message in reply to:

No News = is NOT bad news (except for the impatient and the Bad news only in their individual heads).
Bad News = Bad News

REMEMBER... No News is...

No News = is still POTENTIALLY GOOD NEWS
Positive News = is GOOD NEWS

Meanwhile...every time a repeat of a list is published and BRILACIDIN is listed...MORE EYEBALLS SEE IT...

...and is likely attracting new shareholders in taking a chance on investing (speculating)








To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.